ACT MALI: Treatment of Malaria Based on Combination Therapies

NCT00452907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artesunate
DRUG: Artesunate + Sulfadoxine-Pyrimethamine
DRUG: arthemether + lumefantrine

Sponsor

Sanofi